Skip to main content
Terug
Watch Compare

Cell Source, Inc.

Datakwaliteit: 83%
CLCS
OTC Manufacturing Chemicals
€ 0,84
▲ € 0,06 (8,03%)
Marktkapitalisatie: 37,83 M
Prijs
€ 0,84
Marktkapitalisatie
37,83 M
Dagbereik
—
52-Weeksbereik
—
Volume
—
Openen —
50D / 200D Gem.
—
50D / 200D Gem.
—

Quick Summary

Belangrijkste Punten

Negative free cash flow of -2,68 M

Groei

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
N/A
ROIC-873,75%
Net MarginN/A
Op. MarginN/A

Veiligheid

Debt / Equity
N/A
Current RatioN/A
Interest CoverageN/A

Waardering

PE (TTM)
-8,38
Onder sectorgemiddelde (-1,47)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (1364 peers)
Metriek Aandeel Sector Mediaan
P/E -8,4 -1,5
P/B — 1,6
ROE % — -53,3
Net Margin % — -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3

Koersdoel Analisten

Geen analistendekking beschikbaar

Winstschattingen

Geen toekomstige schattingen beschikbaar

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -4,51 M
ROE N/A ROA -1299,67%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -2,68 M
ROIC -873,75% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio N/A
Interest Coverage N/A Asset Turnover N/A
Working Capital N/A Tangible Book Value -18,94 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -8,38 Forward P/E N/A
P/B Ratio N/A P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -7,09%
Market Cap 37,83 M Enterprise Value 37,83 M
Per Share
EPS (Diluted TTM) -0,14 Revenue / Share N/A
FCF / Share -0,06 OCF / Share -0,06
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 59,48%
SBC-Adj. FCF -2,99 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Revenue — — — — —
Net Income -4,51 M -5,32 M -5,17 M -5,47 M -4,56 M
EPS (Diluted) -0,14 -0,17 -0,18 — —
Gross Profit — — — — —
Operating Income -3,84 M -4,33 M -4,18 M -4,02 M -3,64 M
EBITDA — — — — —
R&D Expenses — — 1,94 M 1,27 M 834.943,0
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense — — — 629.201,0 457.371,0
Income Tax — — — — 0,0

Balance Sheet

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Total Assets 286.500,0 195.171,0 409.845,0 313.767,0 452.339,0
Total Liabilities 18,82 M 15,81 M 13,04 M — 8,40 M
Shareholders' Equity -18,54 M -15,61 M -12,63 M -9,83 M -7,95 M
Total Debt — — — — —
Cash & Equivalents — — 222.665,0 93.095,0 245.119,0
Current Assets — — — 313.767,0 —
Current Liabilities — — — 10,14 M 8,40 M